Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2026-01-05 @ 5:59 AM
Study NCT ID:
NCT01854918
Status:
COMPLETED
Last Update Posted:
2019-06-11
First Post:
2013-05-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-01
First Submit QC Date:
None
Study First Post Date:
2013-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-20
Results First Submit QC Date:
None
Results First Post Date:
2019-06-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-20
Last Update Post Date:
2019-06-11
Last Update Post Date Type:
ACTUAL